Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic acid, N-[(6-hydroxybenzo[b]thien-2-yl)iminomethyl]-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

947590-65-0

Post Buying Request

947590-65-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

947590-65-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 947590-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,5,9 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 947590-65:
(8*9)+(7*4)+(6*7)+(5*5)+(4*9)+(3*0)+(2*6)+(1*5)=220
220 % 10 = 0
So 947590-65-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H16N2O3S/c1-14(2,3)19-13(18)16-8-15-12-6-9-4-5-10(17)7-11(9)20-12/h4-8,17H,1-3H3,(H,15,16,18)

947590-65-0Relevant academic research and scientific papers

Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis

Wang, Shouming,Beck, Richard,Blench, Toby,Burd, Andrew,Buxton, Stuart,Malic, Maja,Ayele, Tenagne,Shaikh, Shaheda,Chahwala, Suresh,Criandera, Chaman,Holland, Richard,Merette, Sandrine,Zhao, Lihua,Blackney, Michael,Watts, Alexandra

experimental part, p. 1465 - 1472 (2010/07/05)

FIXa is a serine protease enzyme involved in the intrinsic pathway of the coagulation cascade. The upstream intervention of the coagulation cascade in selectively inhibiting FIXa would leave hemostasia intact via the extrinsic pathway, leading to an optim

HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISEASE

-

Page/Page column 233-234, (2008/06/13)

Heterocyclic compounds of the formula (I) are provided: wherein ring A, ring B, R1, R2, R3, R4, Y, m, n and q are as defined herein. R1 is in particular amidino. The invention further provides particular benzothiophene compounds. Compounds of the invention may be useful as inhibitors of Factor IXa and in the therapy of cardiovascular conditions and diseases, e.g. thrombosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 947590-65-0